Jeffrey Comitalo, MD
Surgery · Pensacola, FLNPI 1679567697
Payments from drug & device makers
Across 54 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$307
- Davol Inc.$87
- Intuitive Surgical$77
- Baxter Healthcare$70
- Regeneron Healthcare Solutions, Inc.$54
- Abbott$52
- plus $567 from 21 others
What the payments were for
- Food & beverage$1,214100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 15 | $307 |
| Davol Inc. | 3 | $87 |
| Intuitive Surgical | 1 | $77 |
| Baxter Healthcare | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Abbott | 2 | $52 |
| Zimvie Inc. | 2 | $47 |
| Medtronic | 3 | $47 |
| Si-bone, Inc. | 3 | $46 |
| Kerecis Limited | 1 | $46 |
| Radius Health, Inc. | 2 | $41 |
| Cerapedics Inc. | 1 | $39 |
| Sanofi | 2 | $33 |
| Mimedx Group, Inc. | 1 | $31 |
| Conmed Corporation | 1 | $29 |
| Covidien LP | 1 | $24 |
| Organogenesis Inc. | 1 | $23 |
| Solventum Corporation | 1 | $22 |
| Vericel Corporation | 1 | $17 |
| Bioventus LLC | 1 | $17 |
| Merck | 1 | $16 |
| Novartis | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $15 |
| Merit Medical Systems Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Focal Therapeutics, Inc. | 1 | $13 |
How this compares
$1,214 in reported general payments places this provider in the 35th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 78 | $617 |
Paid to pharmacies, not to this prescriber.
Other surgery in Pensacola
- Patrick GatmaitanPensacola$267K
- Kurt StockampPensacola$160K
- Jorge FlorinWinter Garden$2.2M
- Steven FagienBoca Raton$1.6M
- John MullinaxTampa$1.5M
- Amit TaggarTampa$1.4M
- Panagiotis SarantosGainesville$1.3M
- Keith KimCelebration$1.1M
- Christopher DucoinTampa$1.1M
- Andre TeixeiraOcala$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.